{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-113064","form_type":"8-K","ticker":"PAHC","cik":"0001069899","company_name":"PHIBRO ANIMAL HEALTH CORP","filed_at":"2024-10-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.571482+00:00","generated_at":"2026-05-30T07:14:19.173261+00:00","sec_items":["2.01","9.01","2.03","7.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Phibro completes $350M acquisition of Zoetis' medicated feed additive portfolio","bullets":["Acquired >37 product lines across ~80 countries, six manufacturing sites in US, Italy, China, and >300 employees.","Funded with $350M cash: $189M Delayed Draw Term A-1 Loans and $161M A-2 Loans under existing credit agreement.","Expected to boost profitability, EBITDA margin, and be accretive to adjusted EPS; more details on Nov 7 Q1 call.","Portfolio complements Phibro's vaccines, nutritional specialties, and mineral nutrition."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-113064","json":"https://secwatch.observer/filing/0001104659-24-113064.json","markdown":"https://secwatch.observer/filing/0001104659-24-113064.md","text":"https://secwatch.observer/filing/0001104659-24-113064.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1069899/000110465924113064/0001104659-24-113064-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1069899/000110465924113064/tm2427228d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T07:14:19.173261+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}